Journal article

Occult Gastrointestinal Perforation in a Patient With EGFR-Mutant Non-Small-Cell Lung Cancer Receiving Combination Chemotherapy With Atezolizumab and Bevacizumab: Brief Report

Ashray Gunjur, Geoff Chong, Adeline Lim, Eddie Lau, Paul Mitchell, Thomas John, Surein Arulananda

Clinical Lung Cancer | CIG MEDIA GROUP, LP | Published : 2020

DOI: 10.1016/j.cllc.2019.11.014

Citation metrics

1Web of Science

Keywords

Life Sciences & Biomedicine
Gastro-Oesophageal Perforation
Nsclc
Phase-Iii Trial
Oncology
Placebo
Bevacizumab
Science & Technology
Toxicities
1st-Line Therapy
Gemcitabine
Sabr
Egfr-Mutant